Choline‐related‐inherited metabolic diseases—A mini review. Issue 2 (25th January 2019)

• Record Type: Journal Article
• Authors: Wortmann, Saskia B.; Mayr, Johannes A.
• Is Part Of: Journal of inherited metabolic disease. Volume 42:Issue 2(2019)
• Page Start: 237
• Page End: 242
• Publication Date: 2019-01-25
• Subjects: choline -- epilepsy -- fish odor disease -- hereditary spastic paraparesis -- uridine; Metabolism, Inborn errors of -- Periodicals; Metabolism -- Disorders -- Periodicals; 616.39042
• DOI: 10.1002/jimd.12011
• Languages: English
• ISSNs: 0141-8955

Abstract

Abstract: In humans, the important water soluble, vitamin‐like nutrient choline, is taken up with the diet or recycled in the liver. Deficiencies of choline have only been reported in experimental situations or total parenteral nutrition. Currently, no recommended dietary allowances are published; only an adequate daily intake is defined. Choline is involved in three main physiological processes: structural integrity and lipid‐derived signaling for cell membranes, cholinergic neurotransmission, and methylation. Choline is gaining increasing public attention due to studies reporting a relation of low choline levels to subclinical organ dysfunction (nonalcoholic fatty liver or muscle damage), stunting, and neural tube defects. Furthermore, positive effects on memory and a lowering of cardiovascular risks and inflammatory markers have been proposed. On the other hand, dietary choline has been associated with increased atherosclerosis in mice. This mini review will provide a summary of the biochemical pathways, in which choline is involved and their respective inborn errors of metabolism (caused by mutations in SLC5A7, CHAT, SLC44A1, CHKB, PCYT1A, CEPT1, CAD ; DHODH, UMPS, FMO3, DMGDH, and GNMT ). The broad phenotypic spectrum ranging from malodor, intellectual disability, to epilepsy, anemia, or congenital myasthenic syndrome is presented, highlighting the central role of choline within human metabolism.